123 related articles for article (PubMed ID: 6328887)
1. Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkin's disease.
Fisher B; Cheung AY
Acta Radiol Oncol; 1984; 23(1):43-8. PubMed ID: 6328887
[TBL] [Abstract][Full Text] [Related]
2. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
Ortin TT; Shostak CA; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):873-80. PubMed ID: 2211255
[TBL] [Abstract][Full Text] [Related]
3. Pregnancies and menstrual function before and after combined radiation (RT) and chemotherapy (TVPP) for Hodgkin's disease.
Lacher MJ; Toner K
Cancer Invest; 1986; 4(2):93-100. PubMed ID: 3085874
[TBL] [Abstract][Full Text] [Related]
4. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women.
Schuck A; Hamelmann V; Brämswig JH; Könemann S; Rübe C; Hesselmann S; Riesenbeck D; Horst E; Bölling T; Paulussen M; Jürgens H; Willich N
Strahlenther Onkol; 2005 Aug; 181(8):534-9. PubMed ID: 16044222
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced premature menopause: a misconception.
Madsen BL; Giudice L; Donaldson SS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1461-4. PubMed ID: 7635789
[TBL] [Abstract][Full Text] [Related]
6. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
7. Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation.
Thomas PR; Winstanly D; Peckham MJ; Austin DE; Murray MA; Jacobs HS
Br J Cancer; 1976 Feb; 33(2):226-31. PubMed ID: 1259916
[TBL] [Abstract][Full Text] [Related]
8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease.
Hudson MM; Greenwald C; Thompson E; Wilimas J; Marina N; Fairclough D; Kauffman W; Bozeman P; Mackert PW; Abromowitch M
J Clin Oncol; 1993 Jan; 11(1):100-8. PubMed ID: 8418221
[TBL] [Abstract][Full Text] [Related]
10. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
11. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
13. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
14. Female reproductive potential after treatment for Hodgkin's disease.
Horning SJ; Hoppe RT; Kaplan HS; Rosenberg SA
N Engl J Med; 1981 Jun; 304(23):1377-82. PubMed ID: 7231460
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
Brusamolino E; Lunghi F; Orlandi E; Astori C; Passamonti F; Baraté C; Pagnucco G; Baio A; Franchini P; Lazzarino M; Bernasconi C
Haematologica; 2000 Oct; 85(10):1032-9. PubMed ID: 11025593
[TBL] [Abstract][Full Text] [Related]
16. Oophoropexy and the management of Hodgkin's disease. A reevaluation of the risks and benefits.
Gabriel DA; Bernard SA; Lambert J; Croom RD
Arch Surg; 1986 Sep; 121(9):1083-5. PubMed ID: 2943253
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
18. [Ovariopexy and the treatment of Hodgkin's disease].
Grabenbauer GG; Girke P; Wildt L; Müller RG; Herbst M; Sauer R
Strahlenther Onkol; 1991 May; 167(5):273-6. PubMed ID: 2038709
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
Mauch PM; Weinstein H; Botnick L; Belli J; Cassady JR
Cancer; 1983 Mar; 51(5):925-32. PubMed ID: 6687379
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
